Ulrich Medical

Key Findings

• Economic: Gil Medical publicly represents Ulrich Medical in Israel; a 2021 JETRO report independently documents the relationship, and Gil Medical’s partner listing remained observable on 28 October 2026. Individual shipment dates, sales values and current contractual performance remain unverified.^{1, 2}
• Economic: Gil Medical advertises Ulrich spinal implants and fixation products. No public evidence identified of an Ulrich-owned Israeli subsidiary or facility, or of an Ulrich-specific settlement delivery in the reviewed records.^{3, 4}
• Political: JETRO’s 2021 profile separately lists Israel’s Ministry of Defense among Gil Medical’s principal customers. It does not connect that customer to Ulrich products; no Ulrich-specific ministry contract or military delivery was established.²
• Not found: No public evidence identified of Ulrich-specific Israeli military contracting, surveillance provision, government-cloud participation or political financing in the four domain audits. The documented product functions are medical and clinical.^{5, 6, 7, 8}

Target Profile

Executive Summary

Ulrich Medical is a German, privately held family medical-technology company whose disclosed activities concern radiology and spinal surgery. Its documented Israel nexus is commercial representation through Gil Medical, an Israeli medical-equipment distributor. JETRO’s 2021 industry report identifies Ulrich among Gil Medical’s represented manufacturers, while Gil Medical’s own partner listing remained publicly observable on 28 October 2026. Its orthopedic catalogue specifically associates Ulrich with spinal implants and fixation products.^{2, 3, 11, 12}

This establishes an Israeli commercial channel, with important limits. Gil Medical describes nationwide distribution and customer support and identifies an address in Petach Tikva. The retrieved records do not establish the Ulrich relationship’s original commencement date, exclusivity, contractual duration, transaction values or latest shipment. The company’s own locations disclosure identifies operations in Germany, the United States, France and Spain; no public evidence identified of an Ulrich-owned Israeli subsidiary, office, production facility or research centre in the reviewed records.^{1, 4, 15, 16}

The strongest potentially military-adjacent evidence is JETRO’s separate identification of Israel’s Ministry of Defense among Gil Medical’s principal customers in 2021. The report provides no mapping between that customer and Ulrich products. No Ulrich-specific ministry contract, tender, delivery or military end-user was established. Likewise, the audits identified clinical software and hospital-system interfaces, but no public evidence identified of their deployment in Israeli military, surveillance, government-cloud or settlement programmes.^{2, 6, 7, 17}

The political review found no verified Israel-Palestine advocacy, military-directed donation, settlement sponsorship or political-financing act attributable to Ulrich Medical or its named leadership. Documented public sponsorships concern German sitting volleyball and appreciation for nursing professionals. The fixed, human-vetted V6.6 result is BRS 131, Tier E (Minimal/No Complicity): the evidenced nexus is ordinary medical-sector commercial representation, with no substantiated escalation into the military, digital-security or political activities examined.^{5, 18, 19}

Timeline of Relevant Events

Corporate Overview

The operating entity is ulrich GmbH & Co. KG, with ulrich Verwaltungs GmbH identified as its personally liable corporate partner. Official disclosures name Christoph Ulrich as Managing Partner, Friedrich von Rechteren as CEO and Gordon Bittig as CFO. The company describes itself as privately held and family-owned, but the reviewed materials do not disclose an exhaustive beneficial-ownership list or verified percentages for every holder of at least 10% of equity.^{9, 12, 14}

The disclosed group includes ulrich medical USA, Inc., ulrich medical France SAS and ulrich medical España S.L. The US subsidiary dates to 2006 and describes Dallas-area operations, direct spinal-system distribution and development for the US market. The wholly owned French subsidiary dates to October 2017 and operates in the Toulouse area. The Spanish subsidiary was legally established on 10 July 2024, before the separately announced commencement of direct distribution on 1 October 2024. Spain’s registry identifies the German parent as its sole shareholder.^{21, 22, 27, 28}

Outside selected direct markets, Ulrich describes distribution through specialist partners in more than 50 export countries. Gil Medical is the documented Israeli intermediary; no public evidence identified establishing Ulrich ownership of Gil Medical or an Israeli joint venture. Gil Medical’s personnel and premises therefore cannot be counted as Ulrich’s own Israeli workforce or facilities.^{1, 4, 15, 16}

Other commercial relationships require the same attribution discipline. ULRICH Swiss describes itself as independent, although it distributes Ulrich products. GE Healthcare and Bracco Imaging agreements concern US diagnostic-imaging distribution. These relationships do not establish Ulrich-specific Israeli defence or settlement activity, and accessible announcements do not independently confirm the current performance or termination dates of the underlying contracts.^{23, 24, 32}

Domain Summaries

Military: Military

Mechanism of Involvement

No public evidence identified of a direct Ulrich contract, tender award, framework agreement or memorandum with the Israeli Ministry of Defense, IDF, Israel Prison Service, Border Police or another Israeli security organisation in the materials examined. The military audit also identified no verified Ulrich supply of weapons, munitions, military platforms, critical weapons subsystems, construction equipment or military-base logistical services.^{4, 5}

The substantiated product record concerns medical care. CT motion administers contrast agents and saline for diagnostic CT examinations; Max 3 serves MRI and contrast-enhanced mammography. uCentum provides spinal fixation and stabilisation. The examined specifications did not establish purpose-built Israeli military variants, tactical modifications or named Israeli military end-users.^{6, 33, 34}

JETRO’s 2021 Gil Medical profile is relevant but bounded evidence. It identifies both Ulrich as a represented manufacturer and the Ministry of Defense as a distributor customer. It does not identify an Ulrich device supplied to that ministry, a procurement date, a contract value or a military recipient for Ulrich products.²

Counter-Arguments and Evidence Limits

The company’s strongest defence is the documented civilian character of its products and the absence of an established Ulrich-specific military transaction. Medical equipment’s possible usefulness to military healthcare does not establish a military procurement relationship. Gil Medical’s customer list cannot be attributed wholesale to every manufacturer it represents.^{2, 6, 33, 34}

The disclosed GE Healthcare and Bracco arrangements concern US medical imaging. Compatibility between Ulrich spinal systems and third-party surgical navigation equipment likewise documents clinical integration, without establishing military targeting or Israeli defence-prime involvement.^{23, 24, 34}

These findings have limits. Public disclosures do not identify every ultimate purchaser, and undisclosed distributor or intermediary transactions cannot be excluded. The warranted conclusion is “No public evidence identified”, rather than an assurance that no military-related transaction has ever occurred.^{4, 17}

Named Entities and Evidence Map

Digital: Digital

Mechanism of Involvement

Ulrich has documented enterprise software and digital medical functions. Its privacy statement identifies Microsoft Dynamics 365 Customer Insights – Journeys, Microsoft Teams, Google Analytics 4 and Google Ads conversion tracking. These disclosures establish ordinary business processing; they do not establish an Israeli-origin enterprise technology contract or an Israeli processing location.⁸

The RIS/PACS Interface transfers injection and examination information to hospital systems using DICOM. SYNCopen links compatible injectors and CT scanners to support clinical workflows. No public evidence identified of either interface being supplied to an Israeli military, surveillance or settlement programme, and Gil Medical’s listing does not specify sales of these software options.^{7, 17, 35}

No public evidence identified of Ulrich participation in Project Nimbus, an Israeli data centre, Israeli sovereign-cloud services, offensive cyber tools, military AI or an Israeli research laboratory. The reviewed corporate footprint identifies operations elsewhere, while the product and privacy disclosures describe medical interfaces and business services.^{4, 7, 8, 35}

Counter-Arguments and Evidence Limits

The strongest defence is the distinction between clinical information handling and security-sector technology provision. A hospital interface handling patient examination data is not evidence of surveillance, targeting or military intelligence activity. Nor does an Israeli distributor’s representation establish that a particular software module was installed in Israel.^{1, 7, 35}

Vendor use also requires direct attribution. Ulrich’s disclosed Microsoft and Google services do not by themselves establish participation in those vendors’ other customers or programmes. The audited privacy statement does not identify Israeli storage or processing for Ulrich information; its uPortal disclosure states that data is not transferred to third countries for the specified portal processing.⁸

The reviewed materials do not establish every processor, subprocessor, hosting location or hospital installation. No public evidence identified of Israeli routing or storage, but a complete infrastructure audit was not established from those disclosures.^{7, 8}

Named Entities and Evidence Map

Economic: Economic

Mechanism of Involvement

The principal documented nexus is Gil Medical’s representation of Ulrich in Israel. Its dedicated partner page, homepage and orthopedic catalogue establish public commercial presentation of the brand, including spinal implants and fixation products. JETRO independently documents representation in 2021, while Gil Medical’s listing was observable in October 2026.^{1, 2, 3, 15}

Gil Medical identifies its address as 21 Gonen Street, Kiryat Matalon, Petach Tikva, and describes nationwide distribution and support. Its disclosed functions include import management, regulatory affairs, procurement, logistics and customer service. These support the intermediary’s commercial role but do not identify the importer of record for individual Ulrich products.^{15, 16}

No public evidence identified of an Ulrich-owned Israeli business, Israeli acquisition, local workforce, Israeli research centre or controlled property in the reviewed corporate records. No public evidence identified of an Ulrich-specific settlement installation, delivery or maintenance contract. “Nationwide” service language does not establish a delivery destination in occupied territory.^{1, 3, 4}

Group revenue was reported at €163 million for 2024 and €178 million for 2025. Neither report allocates revenue to Israel. No public evidence identified of Israel-specific sales, profits, market share, distribution margins or repatriation arrangements; global turnover therefore cannot substitute for the scale of the documented Israeli relationship.^{1, 29, 31}

Counter-Arguments and Evidence Limits

The strongest defence is that the evidence establishes medical-sector representation through an independent distributor, without substantiating settlement activity, military supply or state financing. Gil Medical’s premises and employees are not established as Ulrich assets or personnel. Its Ministry of Defense customer relationship does not resolve the end-users of Ulrich equipment.^{2, 4, 16}

Public representation must also be distinguished from contractual performance. The audits establish a dated 2021 report and an observable October 2026 listing, not an uninterrupted shipment history between them. The relationship’s original start date, exclusivity, value, latest delivery and current contractual performance remain unverified.^{1, 2}

The October 2026 observation postdates July and November 2024, but it establishes continued public representation, not independently dated product deliveries after either milestone. There is also no documented Israeli divestment or exit to apply as mitigation; the Spanish EuroAutomation transfer concerns a different national market.^{1, 28}

Named Entities and Evidence Map

Political: Political

Mechanism of Involvement

No verified Israel-Palestine political-financing, lobbying, advocacy or settlement-sponsorship act was established. The reviewed news archive contained no identified official statement specifically addressing Israeli military operations in Gaza, Palestinian civilian harm or Israeli settlements. The audited record also identified no relevant military-welfare donation or reservist-support programme.^{5, 13}

Documented public initiatives include the September 2025 sitting-volleyball sponsorship and the September 2026 Nursing Day event. Their stated beneficiaries concern inclusion, sport and healthcare professionals; the cited announcements identify no Israeli state, military or settlement beneficiary.^{18, 19}

The principal potentially political-security connection remains the distributor evidence. JETRO records Gil Medical’s Ministry of Defense customer category, but no Ulrich-specific procurement or political-support act follows from that record.²

Counter-Arguments and Evidence Limits

The strongest defence is the absence of an attributable political act in the reviewed record. Commercial representation in Israel does not itself establish endorsement of state policy. Corporate silence does not establish advocacy, and the audit found no verified comparative statement on another armed conflict from which a specific communications disparity could be demonstrated.^{1, 5}

The compliance framework provides a general whistleblower mechanism. No public evidence identified of Israel-Palestine-related employee discipline, suppression of Palestinian speech, political-content enforcement or a relevant regulatory finding in the reviewed materials. These are bounded search findings, not comprehensive proof about every internal decision.³⁶

Similarly, the ownership record is incomplete. Identified leaders and family ownership are documented, but undisclosed ownership percentages cannot support either allegations of Israeli control or exhaustive assurances about every beneficial owner.^{9, 12, 13}

Named Entities and Evidence Map

Complicity Index Score

Method: V6.6. Final human-vetted scores.

• V_MAX: 1.57 Avg_OTHERS: 0.00
• BRS Score: 131 Tier: E (Minimal/No Complicity)

The economic domain drives V_MAX through documented Israeli medical-device representation, bounded by unverified transaction scale and the absence of established Ulrich-specific military or settlement deliveries.^{1, 2, 3} The remaining domain results are zero, including the fixed Political combination of I=2.00, M=0.00 and P=0.00; the record does not justify inventing an additional political act to explain that retained input. The scale-free, evidence-only, human-vetted method yields Tier E; these fixed values are neither recalculated from global turnover nor expanded through association.

Methodology Note

• This dossier compiles only the four supplied domain audits, researched on 28 October 2026. Citations reproduce their underlying source URLs; negative findings describe the audits’ reviewed materials and searches.
• Impact concerns activity type, M concerns scale, and P concerns directness. Global company size does not establish the magnitude of an Israel-specific activity.
• Historical, current and unresolved relationships are distinguished. Divested or exited operations receive temporal mitigation where documented; webpage availability alone does not establish continuing contractual performance.
• Entity attribution excludes transitive guilt. A distributor’s customer, a vendor’s other programme or a partner’s separate activity is not attributed to Ulrich without evidence connecting the relevant act.
• A verified settlement operation would count in both Economic and Political. No such Ulrich-specific operation was established in the supplied audits.
• “No public evidence identified” denotes a bounded negative finding. Unknown contract terms, shipment dates, ownership percentages and end-users remain unresolved rather than being converted into affirmative allegations or categorical assurances.